SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Cohen who wrote (1361)	5/28/2001 2:42:33 PM
From: Miljenko Zuanic	Read Replies (2) of 1477

That N work better than NTG (which is toxic, btw) is clear to everyone except you (experienced emergency MD). NTG was used as control because of the N safety concern, and to see drug efficacy one more time. Hospitals and emergency rooms (including MDs) make money per days and treatment conditions, not what drugs they used. They will oppose new therapy as long as they can, period. N is used (tested) in addition to other CHF SOC drugs. Yes, N may be expensive drug, but drug economic not price will dictate market penetration. And, this is question which none of as can answer right now. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next